OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DARS-AS1 recruits METTL3/METTL14 to bind and enhance DARS mRNA m 6 A modification and translation for cytoprotective autophagy in cervical cancer
Miaohua Zhu, Weiwei Shen, Qiming Wang, et al.
RNA Biology (2022) Vol. 19, Iss. 1, pp. 751-763
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Methyltransferase-like proteins in cancer biology and potential therapeutic targeting
Yanan Qi, Zhu Liu, Lian‐Lian Hong, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 59

METTL3: a multifunctional regulator in diseases
Na Li, Wei Xiang, J.J. Dai, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access | Times Cited: 2

CL4-modified exosomes deliver lncRNA DARS-AS1 siRNA to suppress triple-negative breast cancer progression and attenuate doxorubicin resistance by inhibiting autophagy
Xinli Liu, Ge Zhang, Tongyao Yu, et al.
International Journal of Biological Macromolecules (2023) Vol. 250, pp. 126147-126147
Closed Access | Times Cited: 28

METTL14 decreases FTH1 mRNA stability via m6A methylation to promote sorafenib-induced ferroptosis of cervical cancer
Lijie Li, Jie Zeng, Sili He, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 11

Mechanistic study of METTL3 inducing ferroptosis to promote cervical cancer progression through mediating m6A modification of COTE-1
Luyao Min, Fu‐Chun Huo, Zhi‐Man Zhu, et al.
Cellular Signalling (2025), pp. 111649-111649
Closed Access | Times Cited: 1

Roles of RNA Methylations in Cancer Progression, Autophagy, and Anticancer Drug Resistance
Hyein Jo, Kyeonghee Shim, Dooil Jeoung
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4225-4225
Open Access | Times Cited: 11

Crosstalk between m6A modification and autophagy in cancer
Tao Chen, Liying Zheng, Peiyue Luo, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4

Landscape of Noncoding RNA in the Hypoxic Tumor Microenvironment
Lianfeng Gong, Chuanxin Zou, Haixia Zhang, et al.
Genes (2025) Vol. 16, Iss. 2, pp. 140-140
Open Access

Epigenetic Regulations in Autoimmunity and Cancer: from Basic Science to Translational Medicine
Hui Li, Ziyue Zhao, Chao Liu, et al.
European Journal of Immunology (2023) Vol. 53, Iss. 4
Open Access | Times Cited: 9

Silencing lncRNA‐DARS‐AS1 suppresses nonsmall cell lung cancer progression by stimulating miR‐302a‐3p to inhibit ACAT1 expression
Ji Li, Yizhuo Li, Xiaodan Sun, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 4, pp. 757-771
Closed Access | Times Cited: 3

N6-Methyladenosine in Cell-Fate Determination of BMSCs: From Mechanism to Applications
Qingyu Zhang, Junyou Li, Cheng Wang, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 3

DARS-AS1: A Vital Oncogenic LncRNA Regulator with Potential for Cancer Prognosis and Therapy
Jian Shu, Kejiang Xia, Hongliang Luo, et al.
International Journal of Medical Sciences (2024) Vol. 21, Iss. 3, pp. 571-582
Open Access | Times Cited: 2

LncRNA DARS-AS1 in human cancers: A comprehensive review of its potency as a biomarker and therapeutic target
Q. Dang
Gene (2024) Vol. 923, pp. 148566-148566
Closed Access | Times Cited: 2

Overview of the interplay between m6A methylation modification and non-coding RNA and their impact on tumor cells
正則 兜, Xiao-Ting Ma, Mei-Na Piao, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 6, pp. 3106-3125
Open Access | Times Cited: 2

Epitranscriptomics and cervical cancer: the emerging role of m6A, m5C and m1A RNA modifications
Akshat D. Modi, Hira Zahid, Ashlyn Chase Southerland, et al.
Expert Reviews in Molecular Medicine (2024) Vol. 26
Closed Access | Times Cited: 2

Noncoding RNAs in the crosstalk between multiple myeloma cells and bone marrow microenvironment
Wenjiao Tang, Juan Xu, Caigang Xu
Cancer Letters (2023) Vol. 556, pp. 216081-216081
Closed Access | Times Cited: 6

The role of RNA methyltransferase METTL3 in gynecologic cancers: Results and mechanisms
Yuxiang Zhang, Na Zhang
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5

Regulatory RNAs: role as scaffolds assembling protein complexes and their epigenetic deregulation
Palmiro Poltronieri
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 4, pp. 841-876
Open Access | Times Cited: 1

m6A modification of RNA in cervical cancer: role and clinical perspectives
Yajuan Gao, Qi Guo, L.‐C. Yu
RNA Biology (2024) Vol. 21, Iss. 1, pp. 49-61
Open Access | Times Cited: 1

Autophagy: a critical mechanism of N6-methyladenosine modification involved in tumor progression and therapy resistance
Feiyang Wang, Qianjin Liao, Zihao Qin, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 10
Open Access | Times Cited: 1

Current and potential roles of RNA modification-mediated autophagy dysregulation in cancer
Hua Huang, Ruining Pan, Sijia Wang, et al.
Archives of Biochemistry and Biophysics (2023) Vol. 736, pp. 109542-109542
Closed Access | Times Cited: 3

The complex nature of lncRNA-mediated chromatin dynamics in multiple myeloma
Patrick Nylund, Berta Garrido-Zabala, Antonia Kalushkova, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2

Interaction between N6-methyladenosine and autophagy in the regulation of bone and tissue degeneration
Xiaodong Wen, Junhu Wang, Qiong Wang, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top